On May 30, Gelonhui reported that shenyang xingqi pharmaceutical (300573.SZ) rose to a new high of 214.36 yuan and then fell back. Its market cap once exceeded 36 billion yuan. The stock has been showing strong momentum recently and has more than doubled from its lows this year. It is reported that the recent surge in the stock is related to a "magic drug" for myopia, which received a drug registration certificate for atropine sulfate eye drops from the National Medical Products Administration. In addition, the net income attributable to shareholders of the listed company in the first quarter was 35 million yuan, a year-on-year increase of 79.59%.
A股异动 | 兴齐眼药盘中再创新高 市值一度超360亿元
A-share changes | Sinqi Pharmaceutical reached a new high in the market, and the market value once exceeded 36 billion yuan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.